VBI Vaccines (VBIV) PT Raised to $7 at BMO Capital After Adding VBI-1901 for GBM to Model
Tweet Send to a Friend
BMO Capital analyst Do Kim raised the price target on VBI Vaccines (NASDAQ: VBIV) to $7.00 (from $4.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
